Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
2.780
-0.150 (-5.12%)
Nov 13, 2026, 4:00 PM EST - Market closed
Adicet Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27.11 | 38.92 | 56.5 | 159.71 | 257.66 | 277.54 |
Short-Term Investments | 73.83 | 119.61 | 119.81 | - | - | - |
Cash & Short-Term Investments | 100.95 | 158.53 | 176.3 | 159.71 | 257.66 | 277.54 |
Cash Growth | -2.09% | -10.08% | 10.39% | -38.01% | -7.17% | 193.34% |
Accounts Receivable | - | - | - | - | - | 0.19 |
Other Receivables | - | 0.34 | 0.1 | - | 0.44 | 0.03 |
Receivables | - | 0.34 | 0.1 | - | 0.44 | 0.21 |
Prepaid Expenses | 2.5 | 2.05 | 3.74 | 2.56 | 2.95 | 4.68 |
Total Current Assets | 103.44 | 160.93 | 180.14 | 162.27 | 261.04 | 282.44 |
Property, Plant & Equipment | 22.85 | 28.48 | 36.75 | 44.2 | 48.98 | 35 |
Goodwill | - | - | - | - | 19.46 | 19.46 |
Other Long-Term Assets | 2.65 | 2.95 | 3.33 | 0.82 | 1.21 | 2.04 |
Total Assets | 128.95 | 192.36 | 220.22 | 207.3 | 330.69 | 338.94 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.7 | 4.74 | 4.83 | 2.63 | 4.4 | 3.26 |
Accrued Expenses | 11.45 | 13.61 | 11.43 | 13.44 | 12.81 | 6.68 |
Current Portion of Leases | 2.85 | 3.19 | 3.13 | 3.22 | 2.49 | 1.57 |
Current Unearned Revenue | - | - | - | - | - | 4.81 |
Total Current Liabilities | 17 | 21.53 | 19.39 | 19.29 | 19.71 | 16.32 |
Long-Term Leases | 9.25 | 11.55 | 14.1 | 17.7 | 18.53 | 19.38 |
Other Long-Term Liabilities | - | 0.06 | 0.12 | 0.13 | 0.11 | 0.12 |
Total Liabilities | 26.25 | 33.15 | 33.61 | 37.12 | 38.35 | 35.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 778.05 | 773.8 | 684.48 | 550.94 | 530.45 | 471.45 |
Retained Earnings | -675.18 | -614.7 | -497.89 | -380.77 | -238.11 | -168.32 |
Comprehensive Income & Other | -0.18 | 0.1 | 0.02 | - | - | - |
Total Common Equity | 102.7 | 159.21 | 186.61 | 170.18 | 292.34 | 303.13 |
Shareholders' Equity | 102.7 | 159.21 | 186.61 | 170.18 | 292.34 | 303.13 |
Total Liabilities & Equity | 128.95 | 192.36 | 220.22 | 207.3 | 330.69 | 338.94 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 12.1 | 14.74 | 17.23 | 20.92 | 21.02 | 20.94 |
Net Cash (Debt) | 88.85 | 143.79 | 159.07 | 138.79 | 236.63 | 256.6 |
Net Cash Growth | 1.47% | -9.60% | 14.61% | -41.35% | -7.78% | 251.63% |
Net Cash Per Share | 8.33 | 20.87 | 28.97 | 51.59 | 92.16 | 132.64 |
Filing Date Shares Outstanding | 9.36 | 10.75 | 5.7 | 5.66 | 2.68 | 2.49 |
Total Common Shares Outstanding | 9.36 | 10.74 | 5.69 | 2.7 | 2.68 | 2.48 |
Working Capital | 86.45 | 139.4 | 160.74 | 142.99 | 241.33 | 266.12 |
Book Value Per Share | 10.97 | 14.82 | 32.81 | 62.93 | 108.89 | 122.05 |
Tangible Book Value | 102.7 | 159.21 | 186.61 | 170.18 | 272.88 | 283.67 |
Tangible Book Value Per Share | 10.97 | 14.82 | 32.81 | 62.93 | 101.64 | 114.22 |
Machinery | - | 14.85 | 15 | 14.31 | 7.86 | 6.02 |
Construction In Progress | - | 0.2 | 0.2 | 0.27 | 9.29 | 13.01 |
Leasehold Improvements | - | 28.42 | 28.23 | 26.64 | 19.96 | 1.61 |